Recombinant tryptophan mutants of influenza
US6322967A · kind A · utility
85Cited by
1References
22Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 10, 2000 |
| Grant date | Nov 27, 2001 |
| Priority date | — |
| Expiry date | Jul 10, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/16162
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Recombinant PB2 tryptophan variant influenza viruses, RNA, cDNA and vectors are provided. Also provided are immunogenic compositions containing the variant viruses, methods of producing such viruses and methods for the prophylactic treatment of influenza in humans.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.